You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

β-thalassemia major

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Beta-Thalassemia Trial (CS-101 injection)

Not yet recruiting
  • Beta-Thalassemia
  • CS-101 injection
  • (no location specified)
Sep 27, 2023

ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

Recruiting
  • β-thalassemia
  • β-globin restored autologous hematopoietic stem cells
  • Shenzhen, Guangdong, China
    Shenzhen Children's Hospital
Feb 24, 2023

Thalassemia Major Trial (n-acetylcystine)

Not yet recruiting
  • Thalassemia Major
  • (no location specified)
Mar 9, 2023

ß Thalassemia Major Trial in Shanghai (?-globin reactivated autologous hematopoietic stem cells)

Active, not recruiting
  • β Thalassemia Major
  • γ-globin reactivated autologous hematopoietic stem cells
  • Shanghai, Shanghai, China
    Shanghai Bioray Laboratories Inc.
Oct 9, 2022

Thalassemia Major Trial in Shanghai (?-globin reactivated autologous hematopoietic stem cells)

Not yet recruiting
  • Thalassemia Major
  • γ-globin reactivated autologous hematopoietic stem cells
  • Shanghai, Shanghai, China
    Shanghai Bioray Laboratories Inc
Jul 1, 2022

Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)

Not yet recruiting
  • Thalassemia, Beta
  • Thalassemia Major
  • VGB-Ex01
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Sep 11, 2023

Beta Thalassemia Major Anemia Trial (SP-420)

Not yet recruiting
  • Beta Thalassemia Major Anemia
  • (no location specified)
Jan 20, 2023

Hematologic Diseases Trial in Kunming (BD211 Drug Product)

Enrolling by invitation
  • Hematologic Diseases
  • BD211 Drug Product
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Aug 14, 2021

Thalassemia Major, Transfusion-dependent Anemia Trial in Guangzhou (Luspatercept Injectable Product)

Recruiting
  • Thalassemia Major
  • Transfusion-dependent Anemia
  • Luspatercept Injectable Product
  • Guangzhou, Guangdong, China
    The second affiliated hospital of Sun Yat-sen University
Jul 15, 2022

ß-Thalassemia Major Trial in Shenzhen (ß-globin restored autologous HSC)

Not yet recruiting
  • β-Thalassemia Major
  • β-globin restored autologous HSC
  • Shenzhen, Guangdong, China
    Beijing Genomics Institute At Shenzhen
Oct 13, 2020

Beta Thalassemia Major, Beta Thalassemia Intermedia Trial in Worldwide (SOTATERCEPT (ACE-011))

Completed
  • Beta Thalassemia Major
  • Beta Thalassemia Intermedia
  • SOTATERCEPT (ACE-011)
  • Créteil, France
  • +14 more
Aug 18, 2022

ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

Recruiting
  • β-thalassemia
  • β-globin restored autologous hematopoietic stem cells
  • Shenzhen, Guangdong, China
    Shenzhen University General Hospital
May 8, 2023

Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia

Not yet recruiting
  • Sickle Cell Disease, Beta Thalassemia Intermedia
  • RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
  • (no location specified)
May 30, 2023

Pulmonary Functions and Physical Fitness in ß-thalassemia

Recruiting
  • β-Thalassemia
  • +2 more
  • no intervention
  • Cairo, Egypt
    Esraa Elsayed
Aug 8, 2022

Beta-Thalassemia Trial in Nanning (CS-101)

Recruiting
  • Beta-Thalassemia
  • CS-101
  • Nanning, China
    The First Affiliated Hospital of Guangxi Medical University
Sep 9, 2023

Sickle Cell Disease, Beta Thalassemia-Major Trial in New Hyde Park (alemtuzumab (Campath IH), Fludarabine, Melphalan)

Completed
Has Results
  • Sickle Cell Disease
  • Beta Thalassemia-Major
  • alemtuzumab (Campath IH)
  • +6 more
  • New Hyde Park, New York
    Cohen Children's Medical Center of New York
Jul 30, 2021

Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

Completed
  • Thalassemia, Beta
  • Hydroxyurea and Thalidomide
  • Karachi, Sindh, Pakistan
    Children's Hospital Karachi
Nov 23, 2023

ß-thalassemia Trial in Shanghai (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • Shanghai, China
    Shanghai Ruijin Hospital
Mar 16, 2023

ß-thalassemia Trial (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • (no location specified)
Mar 15, 2023

Transfusion-dependent Beta-Thalassemia Trial in Tianjin (KL003 cell injection Drug Product)

Not yet recruiting
  • Transfusion-dependent Beta-Thalassemia
  • KL003 cell injection Drug Product
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
May 8, 2023

"Iron Overload and Endocrinological Diseases"

Recruiting
  • Iron Overload
  • +4 more
    • Modena, Italy
      Unit of Endocrinology of Azienza Ospedaliero-Universitaria di Mo
    Nov 13, 2023

    Bone Denisty Change in Children With Beta Thalassemia Major

    Not yet recruiting
    • Evaluate Bone Denisty Changes in Children With Beta Thalassemia Major
    • Dexa scan
    • (no location specified)
    Sep 29, 2023

    Beta-thalassemia Trial in Nanning (Luspatercept, Placebo)

    Recruiting
    • Beta-thalassemia
    • Nanning, China
    • +1 more
    Jan 13, 2023

    Luspatercept in Korean Myelodysplastic Syndrome or ß-thalassemia

    Not yet recruiting
    • Myelodysplastic Syndrome
    • Beta Thalassemia
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    The Prevelence of HBB c.93-21 G-A in ß Thalassemia Patients

    Recruiting
    • Beta-Thalassemia
    • ARMS PCR
    • Assiut, Egypt
      Faculty of Medicine Assiut University
    Jan 30, 2023